Pharmaxis Ltd (AU:SNT) has released an update.
Syntara Limited reported a sharp decline in revenues, down 66.9% to $6,399,000, alongside a 33.3% increase in losses at $15,142,000 for the fiscal year ended 30 June 2024. There were no dividends issued, and the company’s net tangible assets per share plummeted from 1.23 cents to 0.38 cents. Additionally, the company has shed its non-operating subsidiaries as part of the Mannitol Business Unit sale.
For further insights into AU:SNT stock, check out TipRanks’ Stock Analysis page.
